Free Trial
NASDAQ:BIB

ProShares Ultra Nasdaq Biotechnology (BIB) Price, Holdings, & News

ProShares Ultra Nasdaq Biotechnology logo
$48.06 +1.14 (+2.43%)
As of 10:20 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Key Stats

Today's Range
$47.30
$47.85
50-Day Range
$39.63
$48.34
52-Week Range
$33.78
$69.56
Volume
904 shs
Average Volume
11,195 shs
Market Capitalization
$49.02 million
Assets Under Management
$47.45 million
Dividend Yield
1.77%
Net Expense Ratio
0.95%
Aggregate Rating
Moderate Buy

ETF Overview

ProShares Ultra Nasdaq Biotechnology Expenses

TypeBIBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.56%0.56%0.54%0.53%
Other Expenses0.39%0.47%0.56%0.52%0.56%
Total Expense1.14%0.75%0.76%0.74%0.73%
Fee Waiver-0.19%-0.67%-0.66%-0.50%-0.63%
Net Expense0.95%0.60%0.63%0.63%0.60%
Receive BIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

BIB ETF News Headlines

ProShares Ultra Nasdaq Biotechn (^BIB-IV)
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
ProShares Ultra Nasdaq Biotechnology
See More Headlines

BIB ETF - Frequently Asked Questions

ProShares Ultra Nasdaq Biotechnology's stock was trading at $50.66 at the beginning of the year. Since then, BIB shares have decreased by 7.4% and is now trading at $46.92.

Shares of BIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares Ultra Nasdaq Biotechnology investors own include Westmoreland Coal (WLB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Meta Platforms (META), Salesforce (CRM).

Fund Details

Issuer
ProShares
Fund Name
ProShares Ultra Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:BIB
Inception Date
4/6/2010
Fund Manager
Michael Neches, Tarak Dave

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
290

Fund Statistics

Assets Under Management
$49.39 million
Average Daily Volume
$7.70 thousand
Discount/Premium
-0.08%
Leveraged
2.00

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors, LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
2
Put Options
49
Call Options
2
Short Interest
21,600 shs

Miscellaneous

Beta
1.63
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Top 10 BIB Holdings

BIB Sector Exposure

BIB Industry Exposure


This page (NASDAQ:BIB) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners